Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$110.00

2.06 (1.91%)

06:29
10/23/19
10/23
06:29
10/23/19
06:29

Eli Lilly reports Q3 EPS $1.48, consensus $1.40

Reports Q3 revenue $5.48B, consensus $5.5B. "Lilly continued to deliver strong results in the third quarter, due in large part to the growth of our newer medicines and our ability to effectively manage costs while supporting global launches in highly competitive classes and funding our next generation of new therapies," said David Ricks, Lilly's chairman and CEO. "Lilly's revenue growth is being driven by volume, not price, as more and more patients are benefiting from our recently launched medicines. Our sustained investments in oncology, diabetes, immunology, and neuroscience research continue to be productive, with several new medicines expected to be submitted, launch and then reach patients over the next few years."

  • 23

    Oct

  • 28

    Oct

LLY Eli Lilly
$110.00

2.06 (1.91%)

09/05/19
09/05/19
UPGRADE
Target $107

Outperform
Incyte upgraded to Outperform from Market Perform at JMP Securities
As previously reported, JMP Securities analyst Reni Benjamin assumed coverage of Incyte (INCY) with an upgraded rating of Outperform and a $107 price target. The analyst cites the "solid fundamentals" of the company's multi-billion dollar Jakafi franchise, including its recent approval in steroid refractory acute graft-versus-host disease, which he believes remains under-appreciated by investors. Benjamin is also positive on Incyte's "marquee" partners that include Novartis (NVS) and Eli Lilly (LLY), along with its $1.7B cash position, diverse pipeline, and strong fundamentals.
09/09/19
PIPR
09/09/19
NO CHANGE
Target $85
PIPR
Neutral
Lilly's 'impressive update' raised bar higher for Blueprint, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said he thinks Eli Lilly (LLY) issued an "impressive update" on selpercatinib at the World Lung meeting, raising the bar for Blueprint Medicines' (BPMC) pralsetinib "meaningfully higher." While selpercatinib's "best-in-class" ORR was maintained, initial durability data could be upwards of 50% better than that of pralsetinib, according to Raymond. While cautioning that his comparison is highly preliminary, Raymond said he worries that LOXO-292's superiority gap against pralsetinib "may be widening." He keeps a Neutral rating on Blueprint shares, which are down about 3% in morning trading to $75.89.
09/25/19
PIPR
09/25/19
NO CHANGE
Target $81
PIPR
Overweight
AbbVie survey supports above-consensus estimates, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on AbbVie (ABBV) shares with an $81 price target following a new rheumatologist survey by his firm's partners Spherix Global Insights. The survey indicates "robust" expectations for the company's oral JAK1 inhibitor Rinvoq, Raymond tells investors in a research note. Rheumatologists project that in six months, Rinvoq will leapfrog Eli Lilly's (LLY) Olumiant to become the second-most prescribed JAK with 5% share, says the analyst, citing the survey. He believes this supports his above-consensus Rinvoq revenue estimates.
10/16/19
BOFA
10/16/19
INITIATION
Target $133
BOFA
Buy
Eli Lilly reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Geoff Meacham reinstated coverage of Eli Lilly with a Buy rating and $133 price target. The analyst sees the company's "high quality, differentiated growth and modest expectations for added pipeline value" as compelling.

TODAY'S FREE FLY STORIES

RBBN

Ribbon Communications

$4.05

-0.04 (-0.98%)

09:01
11/14/19
11/14
09:01
11/14/19
09:01
Hot Stocks
Ribbon Communications announces departure of CEO Franklin Hobbs »

Ribbon Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$57.61

0.6 (1.05%)

, BIIB

Biogen

$281.71

-9.67 (-3.32%)

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Initiation
Ionis Pharmaceuticals, Biogen, Novartis, Roche initiated  »

William Blair says Ionis…

IONS

Ionis Pharmaceuticals

$57.61

0.6 (1.05%)

BIIB

Biogen

$281.71

-9.67 (-3.32%)

NVS

Novartis

$89.90

0.615 (0.69%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

SAFM

Sanderson Farms

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Upgrade
Sanderson Farms rating change  »

Sanderson Farms upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

SPR

Spirit AeroSystems

$89.29

0.42 (0.47%)

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Conference/Events
Spirit AeroSystems management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TLRY

Tilray

$20.96

-0.61 (-2.83%)

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Recommendations
Tilray analyst commentary  »

Tilray price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
11/14/19
11/14
09:00
11/14/19
09:00
General news
The 14k initial claims pop to 225k »

The 14k initial claims…

RBBN

Ribbon Communications

$4.05

-0.04 (-0.98%)

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Hot Stocks
Breaking Hot Stocks news story on Ribbon Communications »

Ribbon Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRVL

Prevail Therapeutics

$9.80

-1.09 (-10.01%)

08:59
11/14/19
11/14
08:59
11/14/19
08:59
Conference/Events
Prevail Therapeutics management to meet with Wedbush »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PDLI

PDL BioPharma

$2.91

-0.025 (-0.85%)

08:59
11/14/19
11/14
08:59
11/14/19
08:59
Hot Stocks
PDL BioPharma responds to escalation of Engine Capital's public campaign »

PDL BioPharma issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJDCY

Nidec

$0.00

(0.00%)

08:57
11/14/19
11/14
08:57
11/14/19
08:57
Conference/Events
Nidec management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

LTRX

Lantronix

$3.15

0.06 (1.94%)

08:56
11/14/19
11/14
08:56
11/14/19
08:56
Conference/Events
Lantronix management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

LNDC

Landec

$10.86

0.195 (1.83%)

08:55
11/14/19
11/14
08:55
11/14/19
08:55
Conference/Events
Landec management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

NETE

Net Element

$4.54

0.02 (0.44%)

08:55
11/14/19
11/14
08:55
11/14/19
08:55
Earnings
Net Element reports Q3 EPS (24c), one est. (13c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRRM

Verra Mobility

$14.70

0.045 (0.31%)

08:55
11/14/19
11/14
08:55
11/14/19
08:55
Syndicate
Verra Mobility 15M share Spot Secondary priced at $14.25 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

DIS

Disney

$148.69

10.13 (7.31%)

, AAPL

Apple

$264.52

2.63 (1.00%)

08:55
11/14/19
11/14
08:55
11/14/19
08:55
Options
Notable open interest changes for November 14th »

Wednesday's total…

DIS

Disney

$148.69

10.13 (7.31%)

AAPL

Apple

$264.52

2.63 (1.00%)

CSCO

Cisco

$48.44

0.06 (0.12%)

AMD

AMD

$37.52

0.81 (2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 12

    Feb

08:55
11/14/19
11/14
08:55
11/14/19
08:55
General news
U.S. equities are under modest downward pressure »

U.S. equities are under…

08:55
11/14/19
11/14
08:55
11/14/19
08:55
General news
Treasury Action: yields are unmoved by the data mix »

Treasury Action: yields…

08:55
11/14/19
11/14
08:55
11/14/19
08:55
General news
Breaking General news story  »

Federal Reserve Board of…

08:55
11/14/19
11/14
08:55
11/14/19
08:55
General news
Breaking General news story  »

Federal Reserve Board of…

08:55
11/14/19
11/14
08:55
11/14/19
08:55
General news
Breaking General news story  »

Chicago Federal Reserve…

GILT

Gilat Satellite

$7.42

-0.06 (-0.80%)

, ENT

Global Eagle

$0.55

-0.0416 (-7.05%)

08:53
11/14/19
11/14
08:53
11/14/19
08:53
Hot Stocks
Global Eagle places $5M order with Gilat's Wavestream for transceivers »

Gilat Satellite Networks…

GILT

Gilat Satellite

$7.42

-0.06 (-0.80%)

ENT

Global Eagle

$0.55

-0.0416 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LNDC

Landec

$10.86

0.195 (1.83%)

08:53
11/14/19
11/14
08:53
11/14/19
08:53
Conference/Events
Landec management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

AAPL

Apple

$264.52

2.63 (1.00%)

08:53
11/14/19
11/14
08:53
11/14/19
08:53
Hot Stocks
Apple announces users can enroll in three health studies through Research app »

Apple announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$25.14

-0.615 (-2.39%)

, VIAB

Viacom

$22.04

-0.52 (-2.30%)

08:52
11/14/19
11/14
08:52
11/14/19
08:52
Hot Stocks
Viacom says Pluto TV has about 20M MAUs »

Viacom management sees…

VIA

Viacom

$25.14

-0.615 (-2.39%)

VIAB

Viacom

$22.04

-0.52 (-2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

TSE

Trinseo

$44.56

-1.065 (-2.33%)

08:51
11/14/19
11/14
08:51
11/14/19
08:51
Downgrade
Trinseo rating change  »

Trinseo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.